Skip to content

The Impact of Intelligent Medication Management on Medication Adherence and Treatment Outcomes in Ophthalmic Chronic Disease Patients

The Impact of Intelligent Medication Management on Medication Adherence and Treatment Outcomes in Ophthalmic Chronic Disease Patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500104807
Enrollment
Unknown
Registered
2025-06-24
Start date
2025-07-01
Completion date
Unknown
Last updated
2025-06-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ophthalmic chronic diseases, such as glaucoma, dry eye syndrome, etc.

Interventions

experimental group:received personalized medication education
control group:None

Sponsors

Eye & ENT Hospital , Fudan University, Shanghai, China
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Inclusion Criteria: 1. Age 18 years or older, regardless of gender; 2. Diagnosed with an ophthalmic chronic disease (such as those that meet the diagnostic criteria for chronic glaucoma or dry eye syndrome) requiring long-term medication treatment as outpatients; 3. The patient or their family members must be able to use a smartphone; 4. Voluntary participation in this project.

Exclusion criteria

Exclusion criteria: Exclusion Criteria: 1. Patients with acute ophthalmic diseases requiring surgical treatment or intravenous therapy; 2. Patients with severe ocular infections.

Design outcomes

Primary

MeasureTime frame
Medication Adherence Score;

Countries

China

Contacts

Public ContactTaomin Huang

Eye & ENT Hospital , Fudan University, Shanghai, China

taominhuang@126.com+86 189 1778 6061

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026